Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Looking to expand your small business? Discover various ways to explore new opportunities and drive growth effectively.
20,508 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...
Deadly protests in Pakistan’s Karachi and Gilgit-Baltistan have left at least 22 dead and more than 120 injured as cr...
Biotech giants 2026 could offer a compelling mix of growth and stability for investors. This article dives into two p...
As Oracle charts its path through cloud momentum and legacy revenue, investors want clarity on 2026 earnings. This gu...
When a quarterly earnings call drops, investors seek signals that move prices. This practical guide uses the caap 202...
Investors brace for potential disruption as Trump-Iran brinkmanship over the Strait of Hormuz raises the risk of oil ...
After a sharp early-2026 retreat, Shopify looks set to re-rate as cash flow strengthens, a new buyback supports the s...
A U.S. electronics maker and a Chinese supplier are reshaping their supplier networks to weather tariff shocks and ge...
A strategic shift in how the government engages with industry is triggering a market rethink. The administration is t...
Late Saturday, gunfire near the White House prompted a rapid security response. Authorities reported no injuries, whi...
Tech leadership from Microsoft helped major indexes climb, even as headlines shifted. Learn what this means for portf...